These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 23486550

  • 21. Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States.
    Hariri S, Schuler MS, Naleway AL, Daley MF, Weinmann S, Crane B, Newcomer SR, Tolsma D, Markowitz LE.
    Am J Epidemiol; 2018 Feb 01; 187(2):298-305. PubMed ID: 28641366
    [Abstract] [Full Text] [Related]

  • 22. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V, Fett S, Tauscher M, Donnachie E, Schneider A, Klug SJ.
    BMC Cancer; 2022 Dec 09; 22(1):1293. PubMed ID: 36494790
    [Abstract] [Full Text] [Related]

  • 23. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL, Joura EA.
    BioDrugs; 2011 Oct 01; 25(5):339-43. PubMed ID: 21942919
    [Abstract] [Full Text] [Related]

  • 24. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
    Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.
    BMC Cancer; 2013 Jan 08; 13():10. PubMed ID: 23298365
    [Abstract] [Full Text] [Related]

  • 25. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM.
    BMC Med; 2013 Oct 22; 11():227. PubMed ID: 24148310
    [Abstract] [Full Text] [Related]

  • 26. Health and economic implications of HPV vaccination in the United States.
    Kim JJ, Goldie SJ.
    N Engl J Med; 2008 Aug 21; 359(8):821-32. PubMed ID: 18716299
    [Abstract] [Full Text] [Related]

  • 27. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A, Iftner T, Iftner A, Riedle S, Ocak M, Luyten A, Üye I, Tunc K, Petry KU.
    BMC Infect Dis; 2021 Jul 02; 21(1):634. PubMed ID: 34215215
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.
    Aponte-González J, Fajardo-Bernal L, Diaz J, Eslava-Schmalbach J, Gamboa O, Hay JW.
    PLoS One; 2013 Jul 02; 8(11):e80639. PubMed ID: 24260441
    [Abstract] [Full Text] [Related]

  • 29. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P, Tobe K, Abe M, Elbasha EH.
    BMC Infect Dis; 2021 Jan 06; 21(1):11. PubMed ID: 33407188
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HPV Vaccination and the Risk of Invasive Cervical Cancer.
    Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P.
    N Engl J Med; 2020 Oct 01; 383(14):1340-1348. PubMed ID: 32997908
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
    Woestenberg PJ, Guevara Morel AE, Bogaards JA, Hooiveld M, Schurink-van 't Klooster TM, Hoebe CJPA, van der Sande MAB, van Benthem BHB.
    Clin Infect Dis; 2021 Jul 15; 73(2):291-297. PubMed ID: 32421775
    [Abstract] [Full Text] [Related]

  • 38. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM, Brotherton JM, Saville M.
    Sex Health; 2011 Jun 15; 8(2):171-8. PubMed ID: 21592430
    [Abstract] [Full Text] [Related]

  • 39. Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis.
    Brotherton JM, Budd A, Rompotis C, Bartlett N, Malloy MJ, Andersen RL, Coulter KA, Couvee PW, Steel N, Ward GH, Saville M.
    Papillomavirus Res; 2019 Dec 15; 8():100177. PubMed ID: 31319173
    [Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of different human papillomavirus vaccines in Singapore.
    Lee VJ, Tay SK, Teoh YL, Tok MY.
    BMC Public Health; 2011 Mar 31; 11():203. PubMed ID: 21453537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.